ArticleFrontiers in oncology2021

Evaluation of Microwave Ablation in 4T1 Breast Tumor by a Novel VEFGR2 Targeted Ultrasound Contrast Agents.

Xiaoyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.